How to Document Major Depressive Disorder Treatment: Progress Notes for MDD, Persistent Depressive Disorder, and Treatment-Resistant Depression

A clinical documentation guide for therapists treating depression. Covers PHQ-9 score tracking and interpretation, behavioral activation documentation, suicidality risk assessment at each session, medication coordination with prescribers, treatment-resistant depression step-care decisions, functional impairment across occupational and interpersonal domains, and common documentation mistakes.

Why Depression Documentation Is Harder Than It Looks

Depression is one of the most prevalent presentations in outpatient mental health. That prevalence can make documentation feel automatic: administer the PHQ-9, note the score, describe what the client said, write a plan. Repeat. The problem is that this approach produces a chart that confirms sessions happened without demonstrating that treatment is occurring.

Major Depressive Disorder (MDD), Persistent Depressive Disorder (PDD) (formerly dysthymia), and Treatment-Resistant Depression (TRD) have meaningfully different documentation requirements. A note written for an acute MDD episode does not capture the long chronicity that defines PDD. A note written for uncomplicated MDD does not document the clinical reasoning that justifies escalating to augmentation strategies or referral for a higher level of care in TRD. Generic depression notes fail all three.

This guide addresses the specific documentation demands of each presentation: PHQ-9 tracking as a longitudinal clinical tool rather than a score collection task, behavioral activation session content, suicidality risk documentation at every session, medication coordination with prescribers, and functional impairment across the domains that matter to utilization reviewers. Two fictional clients will carry examples throughout.

PHQ-9 Score Tracking and Interpretation Over Time

The PHQ-9 (Patient Health Questionnaire-9) is the standard outcome measure for depression in outpatient settings. Its nine items map directly onto the DSM-5 criteria for MDD, and its scoring thresholds are well-established: 1-4 (minimal), 5-9 (mild), 10-14 (moderate), 15-19 (moderately severe), 20-27 (severe).

What distinguishes good documentation from poor documentation is not whether you record the PHQ-9 score. It is whether you record it in a way that tells a clinical story.

A note that reads "PHQ-9: 16" communicates almost nothing. A note that reads "PHQ-9: 16 (down from 22 at intake; previous session: 19; consistent downward trend across 6 sessions; Item 9 stable at 1 [thoughts of being better off dead or hurting yourself; see suicidality section below])" tells a reviewer, a supervisor, or a new clinician exactly where treatment stands.

What to Document at Each Administration

At baseline, record: the total score, any item-level scores that are clinically significant (particularly Item 9, which screens for passive suicidal ideation), the functional impairment item at the close of the PHQ-9 ("How difficult have these problems made it for you to do your work, take care of things at home, or get along with other people?"), and the clinical interpretation connecting the score to the presenting diagnosis.

At follow-up administrations, record: the total score, directional change from baseline and from the prior session, any item-level changes that warrant clinical attention, and your interpretation in plain language. If the total score is improving but Item 5 (poor appetite or overeating) or Item 6 (feeling bad about yourself) is worsening or stagnant, that discrepancy belongs in the note.

Consider Adriana, a 38-year-old high school teacher presenting with MDD, single episode, moderate severity (F32.1). At intake, her PHQ-9 was 18. At session 8 her note reads: "PHQ-9: 12 (reduced from 18 at intake; prior session: 14). Total score reflects continued improvement. Item 1 (little interest or pleasure) reduced from 3 to 2, consistent with client's report of partial re-engagement with weekend activities. Item 3 (sleep problems) remains at 3 across five consecutive administrations despite behavioral activation and sleep hygiene work; this persistence is discussed in the Assessment section below. Item 9: 0, unchanged." That entry documents not just where Adriana stands but what the data means clinically.

PHQ-9 in Persistent Depressive Disorder

PDD requires particular attention to PHQ-9 trajectory, because the presentation is defined by chronicity rather than severity. Many PDD clients will have PHQ-9 scores in the mild-to-moderate range throughout treatment. A score of 7 in a PDD client who has been symptomatic for six years is not minimally symptomatic. It is a persistent, low-grade episode with significant cumulative functional impact. Your notes need to make that framing explicit rather than letting a score of 7 imply that the client is nearly recovered.

For Marcus, a 44-year-old accountant with PDD (F34.1) and a PHQ-9 that has ranged between 6 and 9 across twelve sessions: "PHQ-9: 7 (range 6-9 across 12 sessions; no single-session score reduction suggests acute response; consistent with chronic low-grade depressive course. Minimal threshold met but functional impact is significant: client describes persistent anhedonia, chronic fatigue interfering with work productivity, and interpersonal withdrawal maintained across this scoring range. Medical necessity for continued treatment reflects functional impairment at scores technically in the 'mild' range, not score severity alone."

Behavioral Activation Documentation

Behavioral activation (BA) is one of the most evidence-based interventions for depression, and one of the most poorly documented. Session notes frequently record that behavioral activation "was discussed" or "activity scheduling was reviewed" without capturing the clinical content that makes those phrases meaningful.

BA documentation has three required elements: the activity schedule itself (what was assigned, what was completed, what was not completed), pleasure and mastery ratings for completed activities, and the clinical reasoning connecting the BA work to the depression conceptualization.

Activity Scheduling

Document assigned activities with specificity. Not "exercise this week" but "30-minute walk Monday, Wednesday, and Friday between 7-8am, before school drop-off." This specificity matters because it is the basis for reviewing what the client actually did. A vague assignment produces a vague follow-up: "Client attempted exercise but did not complete it" versus "Client completed Monday walk (30 minutes, reported as planned); did not complete Wednesday or Friday due to reported fatigue upon waking; identified sleep onset time of 1am on Tuesday night as contributing factor."

The second version captures a clinically relevant pattern: BA is disrupted by sleep timing, which points toward a sleep-related intervention alongside the behavioral work.

Pleasure and Mastery Ratings

Pleasure ratings (also called enjoyment ratings) capture how much positive affect the client experienced during the activity, typically on a 0-10 scale. Mastery ratings capture the sense of accomplishment or competence the activity produced, independent of pleasure.

Both ratings are clinically necessary because MDD clients frequently cannot experience pleasure even from activities they complete and manage competently. Documenting both ratings distinguishes the anhedonic pattern (mastery present, pleasure absent) from global disengagement (both absent), and tracks whether positive affect is beginning to return as treatment progresses.

For Adriana at session 5: "Activity review: Client completed three of five scheduled activities. Morning walk on Monday: pleasure 2/10, mastery 6/10. Reading 20 minutes before bed on Tuesday: pleasure 1/10, mastery 4/10. Phone call with sister on Sunday: pleasure 5/10, mastery 7/10. Pattern: mastery ratings consistently exceed pleasure ratings across all completed activities; this is consistent with the anhedonic component of her MDD presentation. Notable: phone call with sister yielded highest pleasure rating this review period (5/10), which represents the first activity rated above 2 for pleasure since intake. Clinical interpretation: early signal of restored social reward; this activity type will be prioritized in next week's schedule."

Documenting Inactivity and Behavioral Avoidance

When a client does not complete assigned activities, the documentation should explore the function of inactivity rather than simply noting non-completion. Behavioral avoidance in depression operates through a reinforcement trap: withdrawal reduces the short-term discomfort of effortful activity, which reinforces further withdrawal. Documenting this mechanism connects the clinical observation to the treatment rationale.

"Client did not complete two of three scheduled activities. Client reported 'not seeing the point' upon waking and returning to sleep until noon on both days. This pattern is consistent with the behavioral avoidance component of her depression: the short-term relief of returning to sleep reinforces withdrawal from scheduled activity. This avoidance cycle will be addressed in session via values-based activation, identifying activities tied to Adriana's self-identified role as a present parent, rather than pleasure-based activation alone."

Suicidality Risk Assessment Documentation at Each Session

Suicidality risk assessment is the most legally and clinically consequential documentation task in depression treatment. It must occur at every session and be recorded in every session note, regardless of whether the client spontaneously raises the topic.

This is non-negotiable. A session note that contains no suicidality documentation creates the impression that the topic was not addressed. If a client experiences a suicide attempt and the chart contains no suicidality documentation from the previous session, the absence becomes a liability.

What the Documentation Must Capture

At minimum, each session note should document: whether suicidal ideation (SI) was present or absent, the nature of ideation if present (passive versus active), the presence or absence of a plan, the presence or absence of intent, access to means, any protective factors discussed, and the clinical judgment call about level of risk.

Passive SI ("I wish I wasn't here," "I'd be relieved if I didn't wake up") without plan or intent represents a different risk profile than active SI with a specific plan and identified means. That distinction must be visible in your documentation.

For Adriana at session 4: "Suicidality screening: Client denies active suicidal ideation. Passive ideation endorsed: client reported 'sometimes thinking it would be easier to not exist,' occurring 2-3 times in the past week, without intent or plan. No access concerns identified. PHQ-9 Item 9 rated 1 (several days). Protective factors: two dependent children, strong sense of occupational identity, intact therapeutic alliance. Clinical risk assessment: low to moderate risk; passive ideation present without plan, intent, or means access. Safety plan reviewed and updated: client identified sister as primary contact and confirmed phone number is current. No change in treatment frequency indicated at this time."

For Marcus (PDD with chronic low-grade ideation): "Suicidality screening: Client endorses passive ideation consistent with prior sessions: reports 'a low hum of not wanting to be here' occurring daily. No ideation shift since last session by client report. No plan, no intent. Means: client does not own firearms; household medications reviewed; no stockpiling concern identified by client. Protective factors: adult children, professional identity, commitment to caring for aging mother. Clinical judgment: chronic passive ideation within established baseline; no acute escalation. Frequency of suicidality discussion and current safety plan maintained. The chronic, baseline nature of this ideation is documented here and in the treatment record as a known feature of the PDD presentation."

The phrase "no suicidal ideation" is acceptable when accurate. What is not acceptable is an absence of any suicidality documentation. Zero documentation of a zero finding is still zero documentation.

Safety Planning Documentation

When a safety plan is created or updated, document the specific content: the early warning signs the client identified, internal coping strategies, social contacts with phone numbers confirmed in session, professional contacts, and means restriction steps taken or discussed. Reference the plan in subsequent session notes rather than redrafting it each time: "Safety plan reviewed; client reports no changes since last session; plan remains current."

Medication Coordination with Prescribers

When a therapy client with MDD is also receiving pharmacological treatment, the therapy notes need to reflect that coordination, even when the therapist is not the prescriber.

SSRIs (selective serotonin reuptake inhibitors) and SNRIs (serotonin-norepinephrine reuptake inhibitors) are the first-line antidepressant medications. Common agents include sertraline, escitalopram, fluoxetine, bupropion, venlafaxine, and duloxetine. When these medications are titrated, changed, or augmented, those changes affect therapy engagement and symptom trajectory. They belong in your notes.

Your note does not replicate a prescriber's record. What it documents:

Whether the client is taking medication as prescribed, and any adherence concerns.
Client-reported effects or side effects clinically relevant to therapy (fatigue, sexual side effects affecting relationship functioning, sleep disruption, early activation effects).
The substance of any communication with the prescribing provider.
How medication status is interacting with therapy progress.

For Adriana: "Client reports escitalopram 10mg, initiated 6 weeks ago by Dr. Morales (prescribing psychiatrist). Client describes improved sleep onset since week 4 but persistent early-morning waking; this is documented as a partial medication response and discussed with Dr. Morales via secure message this week. Dr. Morales indicated she plans to discuss dose adjustment at next psychiatry appointment. Therapist will coordinate with Dr. Morales following that appointment. PHQ-9 change consistent with expected timeline for SSRI response: clinically meaningful improvement typically emerges at 4-8 weeks."

Avoid interpretations that exceed your scope. Your note describes what the client reports and what clinical action you took, not neurobiological mechanism.

Augmentation Strategies

Augmentation strategies are pharmacological additions to a first-line antidepressant when that antidepressant has produced only a partial response. Common augmentation agents include lithium, atypical antipsychotics (aripiprazole, quetiapine, olanzapine), and buspirone. When a prescriber adds an augmentation agent, therapy notes should document this transition and its clinical context: "Client reports that Dr. Morales added aripiprazole 2mg to existing escitalopram 10mg following partial response at 8 weeks. Client expressed ambivalence about adding a second medication; this ambivalence was explored in session and is noted as a potential adherence concern to monitor. Therapist and client agreed to include medication adherence in next session's agenda."

Treatment-Resistant Depression: Documenting Step-Care Decisions

Treatment-resistant depression (TRD) is generally defined as inadequate response to two or more adequate antidepressant trials at therapeutic doses for an adequate duration. When a client's depression is not responding to standard first-line treatment, the documentation must explain the clinical reasoning for each step-care decision.

"Step-care" refers to the sequential escalation of treatment intensity: from psychotherapy alone to combined treatment, from first-line antidepressants to augmentation, from outpatient to intensive outpatient, from augmentation to interventional psychiatry referral (TMS, ketamine, ECT). Each step-up decision needs documentation that captures: what the current treatment has and has not achieved, what the clinical evidence for the next step is, and what the informed consent conversation covered.

Documenting Inadequate Response

When therapy alone is not producing meaningful change after an adequate trial, the documentation should reflect that clearly: "After 14 sessions of CBT with behavioral activation, PHQ-9 scores have remained in the moderate range (10-14) without sustained movement below 10. Client continues to report functional impairment across occupational and interpersonal domains consistent with intake levels. Current trajectory does not suggest imminent remission. This session: discussed referral to psychiatry for medication evaluation with client. Client agreed to pursue evaluation. Referral initiated."

Documenting Escalation

When a client is referred to a higher level of care or an interventional treatment, document the clinical rationale, the client's response to the recommendation, and the coordination steps taken: "Client was referred to Dr. Ramos for psychiatric evaluation regarding TMS candidacy following two failed adequate antidepressant trials (sertraline 200mg for 10 weeks and venlafaxine 225mg for 12 weeks, both with partial response only). Transcranial magnetic stimulation discussed with client: mechanism, anticipated treatment schedule, expected response timeline. Client expressed cautious openness. Therapist will continue weekly psychotherapy during TMS course. Coordination plan established with Dr. Ramos's office."

When documenting TRD, it also helps to maintain a longitudinal treatment history in the chart that tracks each intervention, its duration, the dose or intensity, and the response. This history is useful when a client transfers or when a new prescriber needs context quickly.

Functional Impairment Documentation Across Domains

Functional impairment is the clinical evidence that connects symptom presence to medical necessity. Symptoms alone do not justify ongoing treatment in the eyes of a utilization reviewer. Impairment does.

Document impairment across at least three domains at intake, and return to it every 4-6 sessions throughout treatment.

Occupational or academic: Is the client meeting work or academic requirements? Are absences, performance problems, or role failures attributable to depressive symptoms? Adriana: "Client reports grading backlog has grown to 3 weeks of uncorrected work; she has requested an extension from her department head for the first time in her 11-year teaching career, citing illness. She describes sitting at her desk for planned work periods without being able to initiate tasks."

Interpersonal: Is the client maintaining relationships, fulfilling social roles, or withdrawing? Marcus: "Client has declined all social invitations from colleagues for 8 weeks; has not initiated contact with adult children since the holiday period; partner reports he has stopped participating in household conversation in the evenings."

Self-care and health behaviors: Sleep, appetite, hygiene, exercise, medication adherence. Adriana: "Client reports sleeping 10-11 hours daily including naps, consistent with hypersomnia. Reports eating one meal per day most days. Reports showering every 3-4 days due to fatigue and lack of motivation."

These are not dramatic descriptions. They are specific, behaviorally anchored entries that make the impairment legible to anyone reading the chart.

Return to functional impairment at regular intervals and document change explicitly: "Occupational functioning improved since session 6: grading backlog has been reduced from 3 weeks to 1 week. Client initiated student feedback meetings that had been postponed for two months. This change is consistent with PHQ-9 improvement and correlates with increased behavioral activation in professional domain."

Common Documentation Mistakes in Depression Treatment

Treating the PHQ-9 as a Number Instead of a Story

Recording the PHQ-9 score without clinical interpretation is the most common mistake in depression documentation. The score is a data point. Your interpretation of the score, in the context of the client's history and current treatment, is the clinical note. If the score went down 3 points, what does that mean? Is it noise, a trend, or a response to a specific intervention? Say so.

Generic Behavioral Activation Documentation

Notes that say "behavioral activation was discussed" or "activity scheduling reviewed" without specifying the activities, the ratings, and the clinical reasoning do not document treatment. They confirm that the session lasted long enough to raise the topic. The specific activities, the pleasure and mastery ratings, and the interpretation of completion patterns are the clinical content.

Suicidality Documentation Only When the Client Raises It

Suicidality must be assessed and documented at every session. Waiting for the client to bring it up is not a documentation strategy. A note with no suicidality documentation leaves the reader to wonder whether the assessment happened. It also leaves you without a record if you are asked later.

Missing Medication Coordination Notes

When a client is receiving concurrent pharmacological treatment, therapy notes that make no reference to medication status or prescriber communication create a fragmented clinical record. This matters when a new clinician picks up the chart, when an insurer reviews for medical necessity, or when coordination becomes urgent.

Functional Impairment Disappearing After Intake

Functional impairment assessed at intake and then absent from subsequent notes is a missed opportunity and a documentation gap. Ongoing medical necessity depends on ongoing documentation of ongoing impairment, or of the functional recovery that justifies treatment continuation or discharge planning.

PDD Notes That Look Identical to MDD Notes

Persistent Depressive Disorder has its own documentation needs. The chronicity of the presentation, the cumulative functional impact at lower symptom severity, and the long treatment timelines all require language tailored to the PDD course. A PHQ-9 of 7 in a client who has been depressed for nine years is not a near-recovered client. The note should say so.

Goals Written as Aspirations

"Client will improve mood" is not a treatment goal. It cannot be measured, cannot be confirmed, and cannot demonstrate medical necessity. Depression treatment goals need a specific threshold (PHQ-9 below 5, zero missed workdays in a month), a measurement method, and a timeframe. Goals at that level of specificity guide your clinical decisions and satisfy any reviewer who asks to see them.

A Note on Format

DAP format (Data, Assessment, Plan) maps cleanly onto depression treatment sessions. Data carries PHQ-9 scores, activity review outcomes, and symptom report. Assessment carries your clinical interpretation of the data: what the PHQ-9 trajectory means, what the pleasure/mastery pattern suggests, what the suicidality assessment concluded. Plan carries next interventions, between-session assignments, and any coordination steps.

SOAP format works equally well. Subjective captures the client's narrative of the past week; Objective carries standardized scores and measurable behavioral data; Assessment synthesizes both into a clinical picture; Plan records the next steps.

What matters most is that the format you use supports longitudinal tracking. Depression is a disorder that evolves over months, not sessions. A chart that can only be read one note at a time without a visible trajectory across the treatment episode is a chart that cannot demonstrate treatment response.

If you use NotuDocs, you can build a depression note template with dedicated fields for PHQ-9 scores, pleasure and mastery ratings, and suicidality screening, so the prompts are embedded in your workflow from session one rather than added as an afterthought when a reviewer asks.

Documentation Checklist for Depression Treatment

Intake and Initial Sessions

DSM-5 diagnosis with full specifiers and ICD-10 code (MDD: F32.x/F33.x; PDD: F34.1)
PHQ-9 administered: total score, item-level clinical flags, functional impairment item response
Suicidality screened and documented: passive/active ideation, plan, intent, means access, protective factors
Safety plan developed and documented with specific content (warning signs, coping steps, contacts, means restriction)
Functional impairment documented across occupational, interpersonal, and self-care domains
Behavioral activation conceptualization documented: specific avoidance patterns identified
Measurable, behaviorally anchored treatment goals in the treatment plan
Medication status documented if applicable: agent, dose, prescriber name, initiation date

Each Session

Progress and Discharge

Functional impairment re-assessed every 4-6 sessions with explicit comparison to intake levels
Progress toward each treatment goal documented with current measurement
PHQ-9 trajectory visible across multiple data points in the chart
For PDD: chronicity framing maintained in notes throughout treatment
For TRD: longitudinal treatment history maintained; each step-care decision documented with rationale and informed consent
Discharge note includes final PHQ-9 score, functional improvement narrative, and relapse prevention plan